Fukuda Denshi CoFKDSF 83 Piotroski F-Score is 6 as of Jun. 30, 2026, which is 14% below its 10-year median of 7.00. GuruFocus rates FKDSF with a GF Score™ of 83/100 and a GF Value™ of $27.75. The stock has 4 warning signs investors should review. Among 806 Medical Devices & Instruments companies, Fukuda Denshi Co ranks better than 81.02% on this metric.
The zones of discrimination were as such:
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Fukuda Denshi Co has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.
The historical rank and industry rank for Fukuda Denshi Co's Piotroski F-Score or its related term are showing as below:
FKDSF'
s Piotroski F-Score Range Over the Past 10 Years
Min: 5 Med: 7 Max: 8
Current: 6
During the past 13 years, the highest Piotroski F-Score of Fukuda Denshi Co was 8. The lowest was 5. And the median was 7.
Fukuda Denshi Co (OTCPK:FKDSF) Piotroski F-Score Explanation
The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.
He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.
He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.
What he found was something that exceeded his most optimistic expectations.
Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.
Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).
Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.
Fukuda Denshi Co Piotroski F-Score Related Terms
Fukuda Denshi Co Piotroski F-Score Historical Data
* Premium members only.
The historical data trend for Fukuda Denshi Co's Piotroski F-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FKDSF vs ABT, SYK, MDT: Piotroski F-Score Comparison
For the Medical Devices subindustry, Fukuda Denshi Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fukuda Denshi Co Piotroski F-Score vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Fukuda Denshi Co's Piotroski F-Score distribution charts can be found below:
* The bar in red indicates where Fukuda Denshi Co's Piotroski F-Score falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.
Profitability
Question 1. Return on Assets (ROA)
Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
Fukuda Denshi Co's current Net Income (TTM) was 118.4.
==> Positive ==> Score 1.
Question 2. Cash Flow Return on Assets (CFROA)
Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.
Fukuda Denshi Co's return on assets of this year was 0.07974935. Fukuda Denshi Co's return on assets of last year was 0.08944654.
==> Last year is higher ==> Score 0.
Question 4. Quality of Earnings (Accrual)
Compare Cash flow return on assets (2) to return on assets (1)
Fukuda Denshi Co's gearing of this year was 0.00590897. Fukuda Denshi Co's gearing of last year was 0.00600017.
==> This year is lower or equal to last year. ==> Score 1.
Question 6. Change in Working Capital (Liquidity)
Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.
Score 1 if this year's current ratio is higher, 0 if it's lower
Fukuda Denshi Co's current ratio of this year was 3.87855496. Fukuda Denshi Co's current ratio of last year was 3.60995099.
==> This year's current ratio is higher. ==> Score 1.
Question 7. Change in Shares in Issue
Compare the number of shares in issue this year, to the number in issue last year.
Score 0 if there is larger number of shares in issue this year, 1 otherwise.
Fukuda Denshi Co's number of shares in issue this year was 27.495. Fukuda Denshi Co's number of shares in issue last year was 28.827.
==> There is smaller number of shares in issue this year, or the same. ==> Score 1.
Efficiency
Question 8. Change in Gross Margin
Compare this year's gross margin (Gross Profit divided by sales) to last year's.
Score 1 if this year's gross margin is higher, 0 if it's lower.
Fukuda Denshi Co's gross margin of this year was 0.54777169. Fukuda Denshi Co's gross margin of last year was 0.53102388.
==> This year's gross margin is higher. ==> Score 1.
Question 9. Change in asset turnover
Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.
Score 1 if this year's asset turnover ratio is higher, 0 if it's lower
Fukuda Denshi Co's asset turnover of this year was 0.59291003. Fukuda Denshi Co's asset turnover of last year was 0.66829577.
==> Last year's asset turnover is higher ==> Score 0.
Evaluation
Piotroski F-Score
=
Que. 1
+
Que. 2
+
Que. 3
+
Que. 4
+
Que. 5
+
Que. 6
+
Que. 7
+
Que. 8
+
Que. 9
=
1
+
1
+
0
+
1
+
1
+
1
+
1
+
1
+
0
=
7
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Fukuda Denshi Co has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.
Fukuda Denshi Co (FKDSF) has a Piotroski F-Score of 6 as of Jun. 30, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Fukuda Denshi Co and its competitors. This is 14% below median its historical median of 7.00. Over the past decade, Fukuda Denshi Co's Piotroski F-Score has ranged from 5.00 to 8.00. According to the industry distribution chart, Fukuda Denshi Co ranks #153 out of 806 companies in the Medical Devices & Instruments industry, placing it in the top 19%.
Is Fukuda Denshi Co's Piotroski F-Score too high?
Fukuda Denshi Co's current Piotroski F-Score of 6 is 14% below median its 10-year median of 7.00. Over the past 10 years, this metric has ranged from a low of 5.00 to a high of 8.00. The Medical Devices & Instruments industry median Piotroski F-Score is 5.00. Fukuda Denshi Co's value of 6 is 20% above this industry median. Based on the distribution chart, Fukuda Denshi Co ranks #153 out of 806 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Fukuda Denshi Co has a GF Score™ of 83/100, reflecting its overall financial health beyond just this single metric.
How does Fukuda Denshi Co's Piotroski F-Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Fukuda Denshi Co ranks #153 out of 806 companies for Piotroski F-Score. This places Fukuda Denshi Co in the top 19% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. Fukuda Denshi Co's value of 6 is 20% above this benchmark. Historically, Fukuda Denshi Co's own Piotroski F-Score has ranged from 5.00 to 8.00 over the past decade. While the company's 10-year median is 7.00 vs. the industry median of 5.00, Fukuda Denshi Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Medical Devices & Instruments company?
The median Piotroski F-Score among Medical Devices & Instruments companies is 5.00, based on 806 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fukuda Denshi Co's current Piotroski F-Score of 6 is 20% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Fukuda Denshi Co and its competitors. For the Medical Devices & Instruments industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fukuda Denshi Co's current Piotroski F-Score is 6, which is 14% below median its own 10-year median of 7.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fukuda Denshi Co stock overvalued right now?
Fukuda Denshi Co (FKDSF) has a current Piotroski F-Score of 6. The stock's GF Value™ is $27.75, compared to a current price of $42.55 — trading 53.3% above its estimated fair value. The current Piotroski F-Score is 6, which is 14% below median its 10-year median of 7.00 and 20% above the Medical Devices & Instruments industry median of 5.00. Fukuda Denshi Co's overall GF Score™ is 83/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Fukuda Denshi Co (FKDSF), the current Piotroski F-Score is 6 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fukuda Denshi Co (FKDSF) Overvalued in 2026?
Based on GuruFocus' analysis, Fukuda Denshi Co stock appears to be overvalued.
The current stock price of $42.55 is trading 53.3% above its estimated GF Value™ of $27.75.
Key valuation signals for FKDSF:
Piotroski F-Score: 6 (14% below median its 10-year median of 7.00)
GF Value™: $27.75 vs. price of $42.55 (53.3% above fair value)
Industry Position: 20% above the Medical Devices & Instruments median (#153 of 806)
No single metric tells the full story. See the FKDSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fukuda Denshi Co Ltd develops and manufactures medical electronic equipment. The firm operates in four segments: physiological diagnostic equipment, patient monitoring equipment, medical treatment equipment, and consumables and other products. The physiological diagnostic equipment business sells electrocardiographs, vascular screening systems, and blood cell counters. The patient monitoring equipment segment sells patient monitors and transmitters. The medical treatment equipment segment contributes the largest proportion of revenue and sells pacemakers and medical equipment for home treatment. The consumables and other products segment sells disposable electrodes and consumables used for the firm's devices. Fukuda Denshi generates the vast majority of its sales in Japan.
83GF Score
Get the complete analysis for FKDSF
Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FKDSF has been successfully added to your 
